Zoetis Inc.

ZTS Healthcare Drug Manufacturers Specialty & Generic

Zoetis Inc.’s revenue for fiscal 2025 (year ended December 2025) was $9.5 billion, up 2.28% from fiscal 2024.

Revenue
−0.24%
EPS
+2.48%
Free cash flow
+17.4%
Total debt
+37.5%

Quarter to June 2026, against a year earlier

78.79 3.32 −4.04%
Market cap
$33.9B
P/E
13.4×
Fwd P/E
14.2×
Dividend yield
2.59%
F-score
7/9
Altman Z
5.73
Beneish M
−2.45
Dividend safety
88/100
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
P/E ratio
32.48 40.78 29.00 42.15 48.11 56.75 32.56 38.77 29.73 21.11
Piotroski F-Score
7 8 6 6 7 9 4 9 8 7
P/S ratio
5.43 6.63 7.09 10.11 11.79 14.89 8.52 10.61 8.00 5.89
Altman Z-Score
4.46 5.17 4.79 6.26 6.80 9.79 6.26 8.59 7.51 5.73
Altman Z″-Score (non-manufacturers)
4.06 4.79 4.37 4.42 5.00 5.93 5.54 6.45 6.04 6.66
P/FCF ratio
45.26 30.34 27.40 46.67 46.46 66.60 51.89 55.92 32.20 24.44
Beneish M-Score
(2.39) (2.67) (2.51) (2.58) (2.76) (2.44) (2.38) (2.36) (2.61) (2.45)
P/Operating CF
92.89 57.83 70.76 108.73 109.60 170.48 92.92 101.06 81.77 62.48
Dividend Safety Score
— — — — — — — — — 88
P/B ratio
17.72 19.69 18.91 23.37 20.86 25.47 15.64 18.16 15.51 16.34
EV/Sales
6.20 7.41 7.91 10.83 12.33 15.29 9.06 11.14 8.49 6.73
EV/EBITDA
18.55 20.24 20.90 27.83 30.84 37.63 21.90 25.96 20.39 15.66
EV/FCF
51.64 33.91 30.55 50.00 48.58 68.41 55.15 58.72 34.20 27.92
Current Ratio
3.03 3.85 3.60 2.63 3.05 3.86 2.37 3.36 1.75 3.03
Net Debt/EBITDA
2.29 1.75 2.16 1.85 1.35 1.00 1.29 1.23 1.19 1.65
Debt/Equity
2.98 2.77 2.95 2.38 1.91 1.46 1.80 1.32 1.38 2.71
ROE
63.40% 52.60% 71.92% 61.31% 50.55% 48.98% 47.26% 49.90% 50.94% 65.99%
ROA
10.55% 10.64% 14.75% 13.44% 13.02% 14.81% 14.67% 16.05% 17.43% 18.00%
ROIC
14.65% 18.42% 15.23% 15.59% 16.93% 20.22% 19.02% 19.28% 20.94% 20.87%
Return on Tangible Assets
22.47% 18.96% 29.54% 30.73% 24.66% 26.96% 29.81% 30.61% 41.68% 32.54%
Average Days of Receivables
68.18 68.64 64.92 63.32 55.39 53.18 54.89 55.71 51.90 61.30
Earnings Yield
3.08% 2.45% 3.45% 2.37% 2.08% 1.76% 3.07% 2.58% 3.36% 4.74%
Free Cash Flow Yield
2.21% 3.30% 3.65% 2.14% 2.15% 1.50% 1.93% 1.79% 3.11% 4.09%
Free Cash Flow per Share
1.18 2.37 3.12 2.84 3.56 3.66 2.83 3.52 5.06 5.15
Book value per Share
3.02 3.65 4.52 5.66 7.93 9.58 9.39 10.82 10.50 7.51
Free Cash Flow
587.00 1,159.00 1,508.00 1,356.00 1,694.00 1,738.00 1,327.00 1,621.00 2,298.00 2,283.00
EV/EBIT
21.74 23.12 24.30 33.49 36.95 43.84 25.44 29.98 23.40 17.79
Other line items

Show all line items

Columns are period end dates · fundamentals updated 25 Oct 2026